Search

everythinglearnresearchcommunity

for

Search:↓

Some alopecia treatments might help treat COVID-19, but more research is needed.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

The document says homoeopathic treatments are good for hair regrowth in alopecia areata but doesn't give proof.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

New insights into the causes and treatments for the autoimmune hair loss condition Alopecia areata have been made.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Intestinal intraepithelial lymphocytes are crucial for gut immunity and maintaining the mucosal barrier.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Some medicinal plants can help heal wounds and may lead to new treatments.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Certain gene variations increase male hair loss risk, influenced by hormone levels.

Araliadiol may promote hair growth like minoxidil without being toxic.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Saw palmetto extract may help treat brain tumors by blocking a specific growth signal and blood vessel formation.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Most children with alopecia areata improved with treatment, but those with more hair loss had worse outcomes.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.